What it sells
AI-powered care for seniors with chronic disease
Business model breakdown
Buyer: who owns the budget?
UnverifiedHealth plan population health / medical management teams (Medicare Advantage); also referring physicians.
Trigger: what makes them buy now?
COPD is costly in MA plans (high-risk COPD members cost $29,564 PMPY, 2.9x non-COPD members) and in-person pulmonary rehab has access barriers.
Workflow: what inputs become what output?
Physician or plan refers patient; 1:1 assessment with respiratory therapist; 9 weeks, 2 live small-group sessions per week (91 minutes) with aerobic/anaerobic exercise, breathing techniques and medication management; then ongoing monitoring.
Economics: what it saves and how it charges
Sold to health plans on cost-savings ROI: claims 3.1x ROI, predicted $8,245 PMPY savings, about $9.8M per 100,000 MA members, mainly from reduced inpatient and SNF costs.
Distribution: how it reaches customers
Demo/contact-sales to health plans and population-health buyers, plus physician referral and patient self-referral forms.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Winter 2023 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.